January 09, 2023 | by BBI Communications
BBI’s Dr. Danny Miller and the UW’s Nanopore Sequencing Core providing targeted and whole genome long-read sequencing of both DNA and RNA to assist researchers with projects that could benefit from long-read sequencing technology
Read MoreSeptember 06, 2022 | by BBI Communications
BBI will be well-represented at the upcoming conference of the Impact of Genomic Variation on Function, (IGVF), September 21 through 23, with presentations by three researchers.
Read MoreJune 30, 2022 | by BBI Communications
BBI’s Dr. Colin Pritchard believes that to chart the future of precision medicine, one needs to look no further than the development of radiology.
Read MoreJune 28, 2022 | by BBI Communications
Genomics and your favorite ice cream sundae: What could be better?
Read MoreApril 29, 2022 | by BBI Communications
A Q&A with BBI researchers reveals why the merger of two sequencing systems was crucial to landmark study
Read MoreApril 29, 2022 | by BBI Communications
BBI’s Dr. Danny Miller and the UW’s Nanopore Sequencing Core are providing both targeted and whole genome long read sequencing on the Oxford Nanopore platform to assist other researchers with their projects.
Read MoreApril 01, 2022 | by BBI Communications
‘Our view of how humans differ from each other is going to be transformed’
Read MoreMarch 17, 2022 | by UW Medicine
The nearly 100,000 whole genome sequences reflect contributions from diverse participants.
Read MoreFebruary 17, 2022 | by BBI Communications
The Brotman Baty Institute Advanced Technology Lab (BAT Lab) will soon be evaluating animal and plant specimens as part of a new UW initiative to help combat international wildlife trafficking.
Read MoreFebruary 02, 2022 | by BBI Communications
Ashley Doyle, a client of BBI’s ConnectMyVariant with hereditary cancer, is making a ‘Herculean effort” to connect with relatives near and far, urging them to seek genetic testing.
Read MoreJanuary 19, 2022 | by Lea Starita
We generate data in our research labs to inform the classification of variants found in people like Chris and Jeanne Evert.
Read MoreOctober 21, 2021 | by BBI Communications
This October marks the one-year anniversary of the Atlas of Variant Effects (AVE) Alliance.
Read MoreSeptember 21, 2021 | by BBI Communications
BBI’s Dr. Doug Fowler on September 16 presented at a National Human Genome Institute’s (NHRGI) “Bold Predictions”: The clinical relevance of all encountered genomic variants will be readily predictable, rendering the diagnostic designation “variant of uncertain significance (VUS)” obsolete.
Read MoreSeptember 09, 2021 | by Written by Michael McCarthy for UW Medicine Newsroom
The National Institutes of Health has awarded $16 million to UW Medicine scientists and their collaborators to fund two projects within the consortium. The funding is part of a 5-year, $185-million initiative sponsored by the NIH’s National Human Genome Research Institute.
Read MoreAugust 18, 2021 | by Gailen Greenstein
This year BBI has three undergraduate interns working at the Fred Hutch, Seattle Children’s Hospital, and the UW Medicine: Amira Ellison, Heidi Solis, and Maria E. Benitez-Cortez. Here, each one offers insights into their passions for their work.
Read MoreJuly 16, 2021 | by BBI Communications
NIH Funds BBI members to participate in new Mendelian Genomics Research Consortium
Read More